News! Some have early access? Hehehe
$Windtree Therapeutics (WINT.US)$ Reuters· just
Windtree Completes Enrollment of Phase 2B Study of Istaroxime in Early Cardiogenic Shock
Windtree Completes Enrollment of Phase 2B Study of Istaroxime in Early Cardiogenic Shock
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Greatvaluetrader1738 : another moomoo news lag?
annna : Then they push the price higher and exit with their profits.
Rockhoundj : I’m in on that dip just now
Not as low as I wanted but thank God for that news
Trytosaveabit OP Rockhoundj : GL!
Rockhoundj Trytosaveabit OP : Well not sure if this is gonna kill it